 
| |
|
|
| press releases
| | |
| | |
|
| Date: |
Title: |
| April
18, 2006 |
TransMolecular
Appoints Dr. Alison M. O’Neill As Vice President of
Medical Affairs |
| April
4, 2006 |
TransMolecular
Appoints Jonathan B. Lloyd Jones As Vice President of Finance |
| November
30, 2005 |
TransMolecular
Expands Management Team |
| November
15, 2005 |
TransMolecular
Relocates Headquarters to Cambridge, MA to Accommodate Next
Phase of Growth |
| December
7, 2004 |
TransMolecular
Successfully Completes Phase I/II Clinical Trial
with its Targeted Oncology Therapeutic |
| September
8, 2004 |
TransMolecular
Names Randall B. Riggs Vice President, Business Development |
| March
1, 2004 |
TransMolecular
Closes $33.2 Million Series C Financing |
| July
10, 2003 |
TransMolecular
Completes Patient Enrollment of Phase I/II Clinical Study
of I-TM-601
to Treat Deadly Form of Brain Cancer |
| June
18, 2002 |
Clinical
Trials to Begin for New Drug to Treat Deadly Form of Brain
Cancer |
| April
18, 2002 |
TransMolecular,
Inc. Awarded Phase II SBIR Grant to Develop New Pain Drug
Therapies |
| May
1, 2001 |
TransMolecular,
Inc. Adds New Board of Director and also Names New Vice President
of Research and Development and New Director of Preclinical
and Clinical Development |
| September
14, 2000 |
TransMolecular,
Inc. Completes $9 Million Series B Round |
| September
13, 2000 |
TransMolecular,
Inc. Receives Two Phase I SBIR Grants |
back to press releases
|
|
|
|
|
| | | | | |
|
| | | | |
| | | | | |
|
|
|
| | |
|
| |
